home / Israel / Compugen

Compugen Market Cap

$0.14 B

+8.15 M

NASDAQ:CGEN · April 19, 2025

Share price

$1.47

Enterprise Value

$37.12 M

Change (1-Year)

17.5%

Global Rank

#7292

Country Rank

#55

Regions

Israel

Market cap

As of April 19, 2025, Compugen (CGEN) has a market cap of $0.14 billion USD. According to our data, Compugen is ranked No.7292 in global market value.

Sector Rank:

Tech #764 Software #343 Biotech #472

CGEN Market Capitalization Growth

1 Years Growth:

17.5%

3 Years Growth:

-7.5%

5 Years Growth:

-84.1%

10 Years Growth:

-68.7%

15 Years Growth:

-53.2%

20 Years Growth:

-41.9%

Total Growth:

-80%

Compugen Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Compugen Market Cap CAGR Chart

Compugen Market Cap History 2000 - 2025

Year	Market Cap	%Change
Apr 19, 2025	$0.14 B	4.93%
Dec 31, 2024	$0.14 B	-22.73%
Dec 29, 2023	$0.18 B	175.00%
Dec 30, 2022	$64.47 M	-83.26%
Dec 31, 2021	$0.39 B	-64.49%
Dec 31, 2020	$1.08 B	103.19%
Dec 31, 2019	$0.53 B	174.65%
Dec 31, 2018	$0.19 B	-13.20%
Dec 29, 2017	$0.22 B	-50.98%
Dec 30, 2016	$0.46 B	-20.19%
Dec 31, 2015	$0.57 B	-23.29%
Dec 31, 2014	$0.75 B	-6.93%
Dec 31, 2013	$0.80 B	81.91%
Dec 31, 2012	$0.44 B	-0.61%
Dec 30, 2011	$0.44 B	0.61%
Dec 31, 2010	$0.44 B	1.44%
Dec 31, 2009	$0.43 B	1,027.91%
Dec 31, 2008	$38.50 M	-73.12%
Dec 31, 2007	$0.14 B	-38.22%
Dec 29, 2006	$0.23 B	-39.20%
Dec 30, 2005	$0.38 B	-17.28%
Dec 31, 2004	$0.46 B	1.98%
Dec 31, 2003	$0.45 B	185.31%
Dec 31, 2002	$0.16 B	-62.34%
Dec 31, 2001	$0.42 B	-24.80%
Dec 29, 2000	$0.56 B	100%

Similar Companies to Compugen

Name	Market Cap	Market cap difference	Regions
Adaptive Biotechnologies ADPT	$1.09 B	0.000 M	USA
BioNTech BNTX	$23.74 B	0.000 M	Germany
Moderna MRNA	$9.56 B	-0.000 M	USA
Illumina ILMN	$11.27 B	-0.000 M	USA
Gilead Sciences GILD	$130.32 B	-0.001 M	USA
Amgen AMGN	$149.09 B	0.124 B	USA
Regeneron Pharmaceuticals REGN	$61.57 B	1.023 B	USA
Vertex Pharmaceuticals VRTX	$125.74 B	-0.003 M	USA
Novavax NVAX	$0.97 B	0.000 M	USA
Incyte INCY	$11.27 B	0.000 M	USA
Alnylam Pharmaceuticals ALNY	$30.36 B	0.000 M	USA
CRISPR Therapeutics CRSP	$3.26 B	0.000 M	Switzerland
Editas Medicine EDIT	$0.11 B	-0.000 M	USA
Beam Therapeutics BEAM	$1.70 B	0.000 M	USA
Intellia Therapeutics NTLA	$0.75 B	-0.000 M	USA

About Compugen Inc.

Name

Compugen Ltd.

Website

https://cgen.com

Headquarters

Holon,None

symbol

CGEN

CURRENCY

USD

country

Israel

fullTimeEmployees

exchange

NCM

firstTradeDateEpochUtc

1969/12/31

CGEN Market Cap Formula

Market Cap	=	CGEN Stock Price	*	CGEN Shares Outstanding
	=	$1.47	*	93.51 M
	=	$0.14 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe